Cutaneous leishmaniasis. Cutaneous leishmaniasis
Conditions
Interventions
Intervention 1: Intervention group: At the same time as intralesional injection of glucantime, after sensitization with 2% diphencyprone (produced by the American corporation Sigma)solution on the upp
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Positive smear or biopsy of the lesion in terms of Leishman body Lesion in limbs dry leishmaniasis The patient has an indication of topical treatment based on the judgment of the therapist and the national protocol for leishmania A maximum of 6 months has elapsed since the onset of the lesion The patient has an informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: Sensitivity to intralesional injection of glucantime The presence of secondary infection in the lesion based on the researcher's judgment Pregnancy or breastfeeding Wet leishmaniasis, Lupoid, Sporotricoid
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rate of recovery in the two groups. Timepoint: Every week after the injection up to 12 weeks. Method of measurement: Size of the lesions will be recorded using a ruler and stiffness and induration will also be recorded based on examination in each session.;The amount of time needed for the lesions to heal. Timepoint: Every week until lesion recovery. Method of measurement: Based on the number of weeks passed until recovery. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFaeze Taghavi
Mashhad University of Medical Sciences
Outcome results
None listed